Telomeres shorten dramatically with human aging and during human carcinogenesis due to insufficient levels of telomerase, the enzyme that synthesizes telomere repeats. This progressive telomere shortening can exert profound effects on tissue homeostasis in both human and mouse, principally in organs with high renewal requirements. In telomerase knockout mice, telomere dysfunction induces high rates of apoptosis and impairs tissue maintenance. The precise mechanisms by which telomere shortening causes these deleterious effects and the specific cell compartments within a tissue that are principally impaired by telomere dysfunction remain to be defined. Telomere shortening is a hallmark of human carcinogenesis, indicating that early stages of tumor development occur in a setting of insufficient levels of telomerase. We have shown that critical telomere shortening in telomerase-deficient, p53-mutant mice leads to cycles of chromosomal fusion-bridge-breakage. This process leads to spontaneous formation of cancer types that resemble those of aging humans - carcinomas - and to the classical chromosomal changes seen in human carcinomas, including non-reciprocal translocations and gene copy number changes. Here, we propose that the mechanism by which telomere dysfunction impairs tissue function is principally by impairing tissue self-renewal and stem/progenitor cell function. Although telomerase is reactivated in 90% of human cancers, our understanding of the advantages conferred by telomerase in tumor progression is incomplete. We have developed a sophisticated mouse model system to directly test these hypotheses using a novel allele of TERT, the catalytic component of telomerase that can be reactivated. This experimental design enables us to study the effect of telomere dysfunction on tissue maintenance, stem/progenitor cell function and on cancer initiation. Furthermore, it provides us with the unique opportunity to reactivate TERT to determine if it can reverse the defects associated with telomere shortening and promote tumor progression.
The aims of the proposal are: (1) To understand how TERT deficiency affects telomere maintenance, chromosomal stability, and apoptosis and p53 responses in epithelial tissues in vivo (2) To ascertain how telomere dysfunction affects mammary epithelial development and stem/progenitor cell function and (3) To determine how TERT reconstitution affects tumor progression and metastasis in a breast cancer-specific model driven by telomere instability. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA111691-04
Application #
7434484
Study Section
Cancer Genetics Study Section (CG)
Program Officer
Jhappan, Chamelli
Project Start
2005-08-15
Project End
2010-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
4
Fiscal Year
2008
Total Cost
$328,430
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Pech, Matthew F; Garbuzov, Alina; Hasegawa, Kazuteru et al. (2015) High telomerase is a hallmark of undifferentiated spermatogonia and is required for maintenance of male germline stem cells. Genes Dev 29:2420-34
Freund, Adam; Zhong, Franklin L; Venteicher, Andrew S et al. (2014) Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1. Cell 159:1389-403
Batista, Luis F Z; Artandi, Steven E (2013) Understanding telomere diseases through analysis of patient-derived iPS cells. Curr Opin Genet Dev 23:526-33
Zhong, Franklin L; Batista, Luis F Z; Freund, Adam et al. (2012) TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell 150:481-94
Shkreli, Marina; Sarin, Kavita Y; Pech, Matthew F et al. (2011) Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med 18:111-9
Zhong, Franklin; Savage, Sharon A; Shkreli, Marina et al. (2011) Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev 25:11-6
Batista, Luis F Z; Pech, Matthew F; Zhong, Franklin L et al. (2011) Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474:399-402
Venteicher, Andrew S; Abreu, Eladio B; Meng, Zhaojing et al. (2009) A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323:644-8
Park, Jae-Il; Venteicher, Andrew S; Hong, Ji Yeon et al. (2009) Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460:66-72
Venteicher, Andrew S; Meng, Zhaojing; Mason, Philip J et al. (2008) Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 132:945-57

Showing the most recent 10 out of 13 publications